This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
home:publications [18.10.2022 15:57] Administrator |
home:publications [15.01.2024 13:53] (current) Administrator |
||
---|---|---|---|
Line 2: | Line 2: | ||
Please find below annual lists of the publications that took advantage of the services provided by Bioinformatics Center. | Please find below annual lists of the publications that took advantage of the services provided by Bioinformatics Center. | ||
+ | |||
+ | ## 2024 | ||
+ | Sallamaari Siponen, Balamuralikrishna Jayaprakash, | ||
+ | Water Research, Volume 248, 2024, 120858, ISSN 0043-1354, https:// | ||
+ | |||
+ | ## 2023 | ||
+ | |||
+ | Juho Mononen, Mari Taipale, Marjo Malinen, Bharadwaja Velidendla, Einari Niskanen, Anna-Liisa Levonen, Anna-Kaisa Ruotsalainen, | ||
+ | |||
+ | Laura Helminen, Jasmin Huttunen, Melina Tulonen, Niina Aaltonen, Einari A Niskanen, Jorma J Palvimo, Ville Paakinaho, **Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer**, Nucleic Acids Research, 2023;, gkad1126, https:// | ||
+ | |||
+ | Csader, S.; Ismaiah, M.J.; Kuningas, T.; Heinäniemi, | ||
+ | |||
+ | Lipponen, A.; Kajevu, N.; Natunen, T.; Ciszek, R.; Puhakka, N.; Hiltunen, M.; Pitkänen, A. **Gene Expression Profile as a Predictor of Seizure Liability**. Int. J. Mol. Sci. 2023, 24, 4116. https:// | ||
## 2022 | ## 2022 | ||
+ | |||
+ | Samms RJ, Cheng CC, Fourcaudot M, Heikkinen S, Khattab A, Adams J, Cersosimo E, Triplitt C, Puckett C, Tsintzas K, Adams AC, Abdul-Ghani MA, DeFronzo RA, Norton L. **FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes** Am J Physiol Endocrinol Metab. 2022 Aug 1; | ||
+ | |||
+ | Kainulainen K, Takabe P, Heikkinen S, Aaltonen N, de la Motte C, Rauhala L, Durst FC, Oikari S, Hukkanen T, Rahunen E, Ikonen E, Hartikainen JM, Ketola K, Pasonen-Seppänen S. **M1 Macrophages Induce Protumor Inflammation in Melanoma Cells through TNFR-NF-κB Signaling** J Invest Dermatol. 2022 Nov; | ||
+ | |||
+ | Kärkkäinen E, Heikkinen S, Tengström M, Kosma VM, Mannermaa A, Hartikainen JM. **Expression profiles of small non-coding RNAs in breast cancer tumors characterize clinicopathological features and show prognostic and predictive potential** Sci Rep. 2022 Dec 30; | ||
+ | |||
+ | Raittio, E, Sofi-Mahmudi, | ||
+ | |||
+ | Ghahremani, Morteza and Khateri, Mohammad and Sierra, Alejandra and Tohka, Jussi, **Adversarial Distortion Learning for Medical Image Denoising**, | ||
+ | |||
+ | Hanel, A.; Carlberg, C. **Time-Resolved Gene Expression Analysis Monitors the Regulation of Inflammatory Mediators and Attenuation of Adaptive Immune Response by Vitamin D**. Int. J. Mol. Sci. 2022, 23, 911. https:// | ||
+ | |||
+ | Luca Cattelani, Vittorio Fortino, **Improved NSGA-II algorithms for multi-objective biomarker discovery, Bioinformatics**, | ||
+ | |||
+ | Maria-Elisa Nordberg, Martin Täubel, Sami Heikkinen, Kaisa Jalkanen, Arto Köliö, Marianne Stranger, Hanna Leppänen, Anne Hyvärinen, Kati Huttunen, **Toxicological transcriptome of human airway constructs after exposure to indoor air particulate matter: In search of relevant pathways of moisture damage-associated health effects**, Environment International, | ||
Jäntti, H., Sitnikova, V., Ishchenko, Y. et al. **Microglial amyloid beta clearance is driven by PIEZO1 channels**. J Neuroinflammation 19, 147 (2022). https:// | Jäntti, H., Sitnikova, V., Ishchenko, Y. et al. **Microglial amyloid beta clearance is driven by PIEZO1 channels**. J Neuroinflammation 19, 147 (2022). https:// |